Filana Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $104.3M | $153.2M |
| FY2009 | — | $108.3M | $35.8M |
| FY2010 | — | $32.9M | $4.8M |
| FY2011 | — | $44.4M | $73.1M |
| FY2012 | — | $13.1M | $49.4M |
| FY2013 | — | $48.3M | $48.6M |
| FY2014 | — | $40.1M | $40.6M |
| FY2015 | — | $29.4M | $31.3M |
| FY2016 | — | $18.6M | $16.6M |
| FY2017 | — | $9.7M | $10.5M |
| FY2018 | — | $19.6M | $19.8M |
| FY2019 | — | $22.1M | $23.1M |
| FY2020 | — | $92.2M | $93.5M |
| FY2021 | — | $253.9M | $233.4M |
| FY2022 | — | $227.5M | $201.0M |
| FY2023 | — | $137.5M | $121.1M |
| FY2024 | — | $145.7M | $128.6M |
| FY2025 | — | $74.4M | $95.5M |